PGRMC1 and cancer: Several other groups showed that PGRMC1 enhanced chemoresistance in several cancer cells such as uterine sarcoma43, breast cancer17, endometrial tumour13 and ovarian cancer44, 45; however, no evidence of PGRMC1-dependent regulation of CYP activity was provided.